<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03093467</url>
  </required_header>
  <id_info>
    <org_study_id>SA16I0173</org_study_id>
    <nct_id>NCT03093467</nct_id>
  </id_info>
  <brief_title>Effectiveness of an Internet-based Intervention for the Treatment of Depression</brief_title>
  <acronym>ASCENSO</acronym>
  <official_title>Effectiveness of an Internet-based Intervention for the Treatment of Depression: Towards the Improvement of the Management of Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Milenio para Investigación en Depresión y Personalidad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Psicomedica Clinical &amp; Research Group, Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondo Nacional de Investigación y Desarrollo en Salud, Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Milenio para Investigación en Depresión y Personalidad</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Depression is a highly prevalent disorder in Chile, generating important personal and social
      costs. This study aims to evaluate the effectiveness of the internet-based program ASCENSO as
      an adjunct intervention for the treatment of depression. ASCENSO provides information to
      promote patients' self-care, it monitors reported depression symptoms providing automatized
      feedback and provides the possibility of booking a counseling session via chat or by phone.
      To evaluate the effectiveness of ASCENSO, an open, evaluator-blind, prospective,
      parallel-group (one intervention group and one active control group) randomized controlled
      trial will be implemented in one mental health center in Santiago of Chile. The sample will
      be composed of adults initiating treatment for depression, and who have internet access.
      Participants will be randomly assigned to one of the two study arms. Randomization will be
      stratified by the number of patients´ previous episodes (dichotomized into none, 1 or more),
      following a permuted block randomization procedure. Patients in the experimental group
      (n=100) will receive the usual treatment plus access to the ASCENSO program. The control
      group (n=100) will only receive the usual treatment. At recruitment, months 6 and 9,
      patients' self-reported depression symptoms and quality of life will be assessed.
      Additionally, adherence to treatment in terms of patients' attendance to medical controls and
      psychotherapy sessions will be registered for both research groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The public health system has established policies and priorities to provide access to
      depression treatment and to improve the quality of those services. The acknowledgment of the
      complexity and chronicity of the disorder has motivated the design and implementation of
      comprehensive disease management strategies for depression. There are experiences that show
      that information technologies can help to optimize the management of depression. If ASCENSO
      is effective, it could be a useful resource to include to the mental health services for
      depression in Chile.

      The components of the ASCENSO program are:

      Emergency. Standard Information on what to do and who to contact in a crisis situation.

      Online or phone counseling. Patients can schedule a 30-minute session with a psychologist,
      which is conducted in a private text chatroom or over the phone.

      Monitoring. Patients receive a bi-weekly email with a link to the monitoring questionnaire
      and automatized tailored feedback message. If a participant reports severe impairment, the
      ASCENSO administrator receives an alert notification and then contacts the patient.

      Self-care information and blog. Web pages with basic information about depression and
      self-care recommendations.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 29, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Open randomized controlled trial in one mental health center.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in depressivity assessed with the Beck's Depression Inventory I (BDI-I)</measure>
    <time_frame>Baseline, months 6 and 9.</time_frame>
    <description>Beck's Depression Inventory I (BDI-I) total score (score range 0 - 63)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life change assessed with the EuroQol/EQ-5D</measure>
    <time_frame>Baseline, months 6 and 9.</time_frame>
    <description>EuroQol/EQ-5D (EQ-index range 0 - 1)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of attended and missed treatment appointments</measure>
    <time_frame>Months 6 and 9.</time_frame>
    <description>Adherence to treatment in terms of patients' attendance to medical controls and psychotherapy sessions.</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of patients that dropout from treatment</measure>
    <time_frame>Months 6 and 9.</time_frame>
    <description>Number of patients that dropout from psychiatric or psychotherapeutic treatment during the observation period.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive psychiatric treatment and psychotherapy as usual. In addition, participants have access to the internet-based program ASCENSO: an adjunct support and monitoring system for the treatment of depression.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive psychiatric treatment and psychotherapy as usual.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ASCENSO</intervention_name>
    <description>Internet-based program: an adjunct support and monitoring system for the treatment of depression.</description>
    <arm_group_label>Experimental</arm_group_label>
    <other_name>Internet-based program</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antidepressants or in combination with anxiolytics, neuroleptics or mood stabilizers.</intervention_name>
    <description>Usual psychiatric treatment which may include drugs: antidepressant monotherapy or antidepressants in combination with anxiolytics, neuroleptics or mood stabilizers as needed, according to the psychiatric evaluation. Monthly controls during 5 months in average.</description>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>Psychiatric treatment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychotherapy</intervention_name>
    <description>Usual treatment: brief psychotherapy. One session per week, a total of 9 sessions in average.</description>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of major depression disorder

          -  Internet access

        Exclusion Criteria:

          -  previous suicide attempt

          -  hospitalization for a previous depressive episode

          -  a history of psychotic symptoms

          -  bipolar disorder

          -  organic brain disorders

          -  any serious disorders related to substance abuse or dependence

          -  antisocial personality disorder

          -  a serious medical condition or severe cognitive impairment

          -  lack of knowledge of the Spanish language

          -  illiteracy

          -  refusal or revocation of patient consent.

        Patients will be evaluated using the MINI International Neuropsychiatric interview, Spanish
        for Chile Translation Version 6.0.0.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Álvaro E. Carrasco, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Millennium institute for research on depression and personality (MIDAP)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Álvaro E. Carrasco, PhD</last_name>
    <phone>56223544843</phone>
    <email>athos@med.uchile.cl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Janet C. Pérez, PhD</last_name>
    <phone>56223544843</phone>
    <email>janetperez@udd.cl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Psicomedica</name>
      <address>
        <city>Santiago</city>
        <state>RM</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristian Caceres</last_name>
      <phone>562675 8700</phone>
      <email>cristian.caceres@psicomedica.cl</email>
    </contact>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <link>
    <url>http://ww3.psicomedica.cl/</url>
    <description>Mental health clinic. Recruitment center.</description>
  </link>
  <link>
    <url>http://midap.org</url>
    <description>Millennium Institute for research on depression and personality</description>
  </link>
  <link>
    <url>http://psyres.de/</url>
    <description>Center for psychotherapy research, Heidelberg University Hospital</description>
  </link>
  <link>
    <url>http://www.conicyt.cl/fonis/</url>
    <description>Fund for research and development in health</description>
  </link>
  <reference>
    <citation>Alvarado R, Rojas G. [Evaluation of the program for detection and treatment of depression in Chilean primary health care centers]. Rev Med Chil. 2011 May;139(5):592-9. doi: /S0034-98872011000500005. Epub 2011 Sep 16. Spanish.</citation>
    <PMID>22051709</PMID>
  </reference>
  <reference>
    <citation>Andersson G, Cuijpers P. Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cogn Behav Ther. 2009;38(4):196-205. doi: 10.1080/16506070903318960.</citation>
    <PMID>20183695</PMID>
  </reference>
  <reference>
    <citation>Espinosa HD, Carrasco Á, Moessner M, Cáceres C, Gloger S, Rojas G, Perez JC, Vanegas J, Bauer S, Krause M. Acceptability Study of &quot;Ascenso&quot;: An Online Program for Monitoring and Supporting Patients with Depression in Chile. Telemed J E Health. 2016 Jul;22(7):577-83. doi: 10.1089/tmj.2015.0124. Epub 2016 Jan 7.</citation>
    <PMID>26741190</PMID>
  </reference>
  <reference>
    <citation>Fritsch R, Araya R, Solís J, Montt E, Pilowsky D, Rojas G. [A randomized trial of pharmacotherapy with telephone monitoring to improve treatment of depression in primary care in Santiago, Chile]. Rev Med Chil. 2007 May;135(5):587-95. Epub 2007 Jul 9. Spanish.</citation>
    <PMID>17657327</PMID>
  </reference>
  <reference>
    <citation>Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015 Feb 24;17(2):e52. doi: 10.2196/jmir.3951. Review.</citation>
    <PMID>25803266</PMID>
  </reference>
  <reference>
    <citation>Kordy H, Wolf M, Aulich K, Bürgy M, Hegerl U, Hüsing J, Puschner B, Rummel-Kluge C, Vedder H, Backenstrass M. Internet-Delivered Disease Management for Recurrent Depression: A Multicenter Randomized Controlled Trial. Psychother Psychosom. 2016;85(2):91-8. doi: 10.1159/000441951. Epub 2016 Jan 26.</citation>
    <PMID>26808817</PMID>
  </reference>
  <reference>
    <citation>Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med Care. 2004 Dec;42(12):1211-21. Review.</citation>
    <PMID>15550801</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>March 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2017</study_first_posted>
  <last_update_submitted>June 1, 2017</last_update_submitted>
  <last_update_submitted_qc>June 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Milenio para Investigación en Depresión y Personalidad</investigator_affiliation>
    <investigator_full_name>Álvaro Carrasco</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>Internet</keyword>
  <keyword>Mental Health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
    <mesh_term>Anti-Anxiety Agents</mesh_term>
    <mesh_term>Antipsychotic Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

